Cargando…
Integration of Nanobots Into Neural Circuits As a Future Therapy for Treating Neurodegenerative Disorders
Recent neuroscientific research demonstrates that the human brain is becoming altered by technological devices. Improvements in biotechnologies and computer based technologies are now increasing the likelihood for the development of brain augmentation devices in the next 20 years. We have developed...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872519/ https://www.ncbi.nlm.nih.gov/pubmed/29618966 http://dx.doi.org/10.3389/fnins.2018.00153 |
_version_ | 1783309854220222464 |
---|---|
author | Saniotis, Arthur Henneberg, Maciej Sawalma, Abdul-Rahman |
author_facet | Saniotis, Arthur Henneberg, Maciej Sawalma, Abdul-Rahman |
author_sort | Saniotis, Arthur |
collection | PubMed |
description | Recent neuroscientific research demonstrates that the human brain is becoming altered by technological devices. Improvements in biotechnologies and computer based technologies are now increasing the likelihood for the development of brain augmentation devices in the next 20 years. We have developed the idea of an “Endomyccorhizae like interface” (ELI) nanocognitive device as a new kind of future neuroprosthetic which aims to facilitate neuronal network properties in individuals with neurodegenerative disorders. The design of our ELI may overcome the problems of invasive neuroprosthetics, post-operative inflammation, and infection and neuroprosthetic degradation. The method in which our ELI is connected and integrated to neuronal networks is based on a mechanism similar to endomyccorhizae which is the oldest and most widespread form of plant symbiosis. We propose that the principle of Endomyccorhizae could be relevant for developing a crossing point between the ELI and neuronal networks. Similar to endomyccorhizae the ELI will be designed to form webs, each of which connects multiple neurons together. The ELI will function to sense action potentials and deliver it to the neurons it connects to. This is expected to compensate for neuronal loss in some neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. |
format | Online Article Text |
id | pubmed-5872519 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-58725192018-04-04 Integration of Nanobots Into Neural Circuits As a Future Therapy for Treating Neurodegenerative Disorders Saniotis, Arthur Henneberg, Maciej Sawalma, Abdul-Rahman Front Neurosci Neuroscience Recent neuroscientific research demonstrates that the human brain is becoming altered by technological devices. Improvements in biotechnologies and computer based technologies are now increasing the likelihood for the development of brain augmentation devices in the next 20 years. We have developed the idea of an “Endomyccorhizae like interface” (ELI) nanocognitive device as a new kind of future neuroprosthetic which aims to facilitate neuronal network properties in individuals with neurodegenerative disorders. The design of our ELI may overcome the problems of invasive neuroprosthetics, post-operative inflammation, and infection and neuroprosthetic degradation. The method in which our ELI is connected and integrated to neuronal networks is based on a mechanism similar to endomyccorhizae which is the oldest and most widespread form of plant symbiosis. We propose that the principle of Endomyccorhizae could be relevant for developing a crossing point between the ELI and neuronal networks. Similar to endomyccorhizae the ELI will be designed to form webs, each of which connects multiple neurons together. The ELI will function to sense action potentials and deliver it to the neurons it connects to. This is expected to compensate for neuronal loss in some neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. Frontiers Media S.A. 2018-03-21 /pmc/articles/PMC5872519/ /pubmed/29618966 http://dx.doi.org/10.3389/fnins.2018.00153 Text en Copyright © 2018 Saniotis, Henneberg and Sawalma. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Saniotis, Arthur Henneberg, Maciej Sawalma, Abdul-Rahman Integration of Nanobots Into Neural Circuits As a Future Therapy for Treating Neurodegenerative Disorders |
title | Integration of Nanobots Into Neural Circuits As a Future Therapy for Treating Neurodegenerative Disorders |
title_full | Integration of Nanobots Into Neural Circuits As a Future Therapy for Treating Neurodegenerative Disorders |
title_fullStr | Integration of Nanobots Into Neural Circuits As a Future Therapy for Treating Neurodegenerative Disorders |
title_full_unstemmed | Integration of Nanobots Into Neural Circuits As a Future Therapy for Treating Neurodegenerative Disorders |
title_short | Integration of Nanobots Into Neural Circuits As a Future Therapy for Treating Neurodegenerative Disorders |
title_sort | integration of nanobots into neural circuits as a future therapy for treating neurodegenerative disorders |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872519/ https://www.ncbi.nlm.nih.gov/pubmed/29618966 http://dx.doi.org/10.3389/fnins.2018.00153 |
work_keys_str_mv | AT saniotisarthur integrationofnanobotsintoneuralcircuitsasafuturetherapyfortreatingneurodegenerativedisorders AT hennebergmaciej integrationofnanobotsintoneuralcircuitsasafuturetherapyfortreatingneurodegenerativedisorders AT sawalmaabdulrahman integrationofnanobotsintoneuralcircuitsasafuturetherapyfortreatingneurodegenerativedisorders |